{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:26:23Z","timestamp":1778019983502,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11033-020-05635-9","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T17:04:21Z","timestamp":1594141461000},"page":"5451-5459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Silybum marianum (milk thistle) improves vancomycin induced nephrotoxicity by downregulating apoptosis"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6454-1525","authenticated-orcid":false,"given":"Naila","family":"Malkani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammara","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidra","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saima","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Imran","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"issue":"7","key":"5635_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1177\/0960327111433185","volume":"31","author":"F Basarslan","year":"2012","unstructured":"Basarslan F, Yilmaz N, Ates S, Ozgur T, Tutanc M, Motor VK, Arica V, Yilmaz C, Inci M, Buyukbas S (2012) Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats. Hum Exp Toxicol 31(7):726\u2013733","journal-title":"Hum Exp Toxicol"},{"key":"5635_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1155\/2015\/704382","volume":"2015","author":"B Humanes","year":"2015","unstructured":"Humanes B, Jado JC, Camano S, Lopez-Parra V, Torres AM, Alvarez-Sala LA, Cercenado E, Tejedor A, Lazaro A (2015) Protective effects of cilastatin against vancomycin-induced nephrotoxicity. Biomed Res Int 2015:12","journal-title":"Biomed Res Int"},{"issue":"5","key":"5635_CR3","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/AAC.03147-14","volume":"60","author":"R Alvarez","year":"2016","unstructured":"Alvarez R, Lopez Cortes LE, Molina J, Cisneros JM, Pachon J (2016) Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother 60(5):2601\u20132609","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5635_CR4","first-page":"21","volume":"31","author":"JH Martin","year":"2010","unstructured":"Martin JH, Norris R, Barras M, Roberts J, Morris R, Doogue M, Jones GR (2010) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists. Clin Biochem Rev 31(1):21\u201324","journal-title":"Clin Biochem Rev"},{"issue":"11","key":"5635_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","volume":"29","author":"MJ Rybak","year":"2009","unstructured":"Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC Jr, Craig WA, Billeter M, Dalovisio JR, Levine DP (2009) Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists. Pharmacother 29(11):1275\u20131279","journal-title":"Pharmacother"},{"issue":"2","key":"5635_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01568-12","volume":"57","author":"SJ Van Hal","year":"2013","unstructured":"Van Hal SJ, Paterson DL, Lodise TP (2013) Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother 57(2):734\u2013744","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"5635_CR7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1440-1681.2007.04695.x","volume":"34","author":"H Cetin","year":"2007","unstructured":"Cetin H, Olgar S, Oktem F, Ciris M, Uz E, Aslan C, Ozguner F (2007) Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model. Clin Exp Pharmacol Physiol 34(11):1181\u20131185","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"5635_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0897190014546114","volume":"27","author":"KA Mergenhagen","year":"2014","unstructured":"Mergenhagen KA, Borton AR (2014) Vancomycin nephrotoxicity: a review. J Pharm Pract 27(6):545\u2013553","journal-title":"J Pharm Pract"},{"issue":"4","key":"5635_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/jac\/25.4.679","volume":"25","author":"MJ Rybak","year":"1990","unstructured":"Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH (1990) Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother 25(4):679\u2013687","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5635_CR10","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.freeradbiomed.2012.02.038","volume":"52","author":"Y Arimura","year":"2012","unstructured":"Arimura Y, Yano T, Hirano M, Sakamoto Y, Egashira N, Oishi R (2012) Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. Free Radic Biol Med 52(9):1865\u20131873","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"5635_CR11","first-page":"379","volume":"69","author":"A Gupta","year":"2011","unstructured":"Gupta A, Biyani M, Khaira A (2011) Vancomycin nephrotoxicity: myths and facts. Neth J Med 69(9):379\u2013383","journal-title":"Neth J Med"},{"issue":"3","key":"5635_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/cpt.726","volume":"102","author":"EJ Filippone","year":"2017","unstructured":"Filippone EJ, Kraft WK, Farber JL (2017) The nephrotoxicity of vancomycin. Clin Pharmacol Ther 102(3):459\u2013469","journal-title":"Clin Pharmacol Ther"},{"key":"5635_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2018.1512612","author":"Z Uckun","year":"2018","unstructured":"Uckun Z, Guzel S, Canacankatan N, Yalaza C, Kibar D, Coskun YB (2018) Potential protective effects of naringenin against vancomycin-induced nephrotoxicity via reduction on apoptotic and oxidative stress markers in rats. Drug Chem Toxicol. https:\/\/doi.org\/10.1080\/01480545.2018.1512612","journal-title":"Drug Chem Toxicol"},{"issue":"11","key":"5635_CR14","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ptr.6171","volume":"32","author":"L Abenavoli","year":"2018","unstructured":"Abenavoli L, Izzo AA, Milic N, Cicala C, Santini A, Capasso R (2018) Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res 32(11):2202\u20132213","journal-title":"Phytother Res"},{"key":"5635_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0021-9673(02)01971-4","volume":"990","author":"F Kvasnicka","year":"2003","unstructured":"Kvasnicka F, Biba B, Sevcik R, Voldrich M, Kratka J (2003) Analysis of the active components of silymarin. J Chromatogr A 990:239\u2013245","journal-title":"J Chromatogr A"},{"issue":"6","key":"5635_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.5152\/tjg.2017.16742","volume":"28","author":"N Alaca","year":"2017","unstructured":"Alaca N, Ozbeyli D, Uslu S, Sahin HH, Yigitturk G, Kurtel H, Oktem G, Caglayan YB (2017) Treatment with milk thistle extract (S. marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: role of the hepatic stem cells. Turk J Gastroenterol 28(6):476\u2013484","journal-title":"Turk J Gastroenterol"},{"key":"5635_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.intimp.2017.06.030","volume":"50","author":"N Esmaeil","year":"2017","unstructured":"Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B (2017) Silymarin impacts on immune system as an immunomodulator: one key for many locks. Int Immunopharmacol 50:194\u2013201","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"5635_CR18","first-page":"308","volume":"14","author":"G Karimi","year":"2011","unstructured":"Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M (2011) \"Silymarin\u201d, a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci 14(4):308\u2013317","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"5635_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/molecules21040443","volume":"21","author":"SH Kim","year":"2016","unstructured":"Kim SH, Oh DS, Oh JY, Son TG, Yuk DY, Jung YS (2016) Silymarin prevents restraint stress-induced acute liver injury by ameliorating oxidative stress and reducing inflammatory response. Molecules 21(4):443","journal-title":"Molecules"},{"key":"5635_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/2008-7802.174762","volume":"7","author":"Z Sedighifard","year":"2016","unstructured":"Sedighifard Z, Roghani F, Bidram P, Harandi SA, Molavi S (2016) Silymarin for the prevention of contrast-induced nephropathy: a placebo-controlled clinical trial. Int J Prev Med 7:23","journal-title":"Int J Prev Med"},{"key":"5635_CR21","unstructured":"Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor L (Cell viability assays. InAssay Guidance Manual [Internet] 2016) Jul 1. Eli Lilly & Company and the National Center for Advancing Translational Sciences"},{"issue":"6","key":"5635_CR22","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/gkp045","volume":"37","author":"JM Ruijter","year":"2009","unstructured":"Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, Van den Hoff MJB, Moorman AFM (2009) Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic acids res 37(6):e45\u2013e45","journal-title":"Nucleic acids res"},{"issue":"9","key":"5635_CR23","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT\u2013PCR. Nucleic Acids Res 29(9):e45\u2013e45","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"5635_CR24","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1128\/AAC.00591-16","volume":"60","author":"NJ Rhodes","year":"2016","unstructured":"Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O\u2019Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH (2016) Evaluation of vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury in vancomycin-treated rats. Antimicrob Agents Chemother 60(10):5742\u20135751","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5635_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1089\/107628003322256878","volume":"9","author":"K Abascal","year":"2003","unstructured":"Abascal K, Yarnell E (2003) The many faces of silybum marianum (Milk Thistle): part 1-treating cancer and hyperlipidemia and restoring kidney function. Altern Complement Ther 9(4):170\u2013175","journal-title":"Altern Complement Ther"},{"key":"5635_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.toxlet.2018.06.1220","volume":"295","author":"S Wen","year":"2018","unstructured":"Wen S, Wang C, Huo X, Meng Q, Liu Z, Yang S, Zhu Y, Sun H, Ma X, Liu K (2018) JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats. Toxicol Lett 295:195\u2013204","journal-title":"Toxicol Lett"},{"issue":"3","key":"5635_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/2042018816638223","volume":"7","author":"O Bamgbola","year":"2016","unstructured":"Bamgbola O (2016) Review of vancomycin-induced renal toxicity: an update. Ther Adv Endocrinol Metab 7(3):136\u2013147","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"4","key":"5635_CR28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00228-012-1406-3","volume":"69","author":"S Elyasi","year":"2013","unstructured":"Elyasi S, Khalili H, Hatamkhani S, Dashti-Khavidaki S (2013) Prevention of vancomycin induced nephrotoxicity: a review of preclinical data. Eur J Clin Pharmacol 69(4):747\u2013754","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"5635_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1742-7843.2007.00051.x","volume":"100","author":"S Ocak","year":"2007","unstructured":"Ocak S, Gorur S, Hakverdi S, Celik S, Erdogan S (2007) Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol 100(5):328\u2013333","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"5635_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/1071576031000061002","volume":"37","author":"Y Nishino","year":"2003","unstructured":"Nishino Y, Takemura S, Minamiyama Y, Hirohashi K, Ogino T, Inoue M, Okada S, Kinoshita H (2003) Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic Res 37(4):373\u2013379","journal-title":"Free Radic Res"},{"key":"5635_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01480545.2019.1584208","volume":"12","author":"S Guzel","year":"2019","unstructured":"Guzel S, Sahinogullari ZU, Canacankatan N, Antmen SE, Kibar D, Coskun YB (2019) Potential renoprotective effects of silymarin against vancomycin-induced nephrotoxicity in rats. Drug Chem Toxicol 12:1\u20137. https:\/\/doi.org\/10.1080\/01480545.2019.1584208","journal-title":"Drug Chem Toxicol"},{"key":"5635_CR32","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.biopha.2018.06.048","volume":"105","author":"FM Kandemir","year":"2018","unstructured":"Kandemir FM, Yildirim S, Kucukler S, Caglayan C, Mahamadu A, Dortbudak MB (2018) Therapeutic efficacy of zingerone against vancomycin-induced oxidative stress, inflammation, apoptosis and aquaporin 1 permeability in rat kidney. Biomed Pharmacother 105:981\u2013991","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"5635_CR33","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1067\/mai.2001.117819","volume":"108","author":"KC Zimmermann","year":"2001","unstructured":"Zimmermann KC, Douglas R (2001) Green. \u201cHow cells die: apoptosis pathways. J Allergy Clin Immunol 108(4):S99\u2013S103","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"5635_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ki.2011.120","volume":"80","author":"A Havasi","year":"2011","unstructured":"Havasi A, Borkan SC (2011) Apoptosis and acute kidney injury. Kidney Int 80(1):29\u201340","journal-title":"Kidney Int"},{"issue":"2","key":"5635_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.femsyr.2004.07.006","volume":"5","author":"W Bursch","year":"2004","unstructured":"Bursch W (2004) Multiple cell death programs: Charon\u2019s lifts to Hades. FEMS Yeast Res 5(2):101\u2013110","journal-title":"FEMS Yeast Res"},{"issue":"4","key":"5635_CR36","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1681\/ASN.V134858","volume":"13","author":"MS Park","year":"2002","unstructured":"Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13(4):858\u2013865","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5635_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1034\/j.1600-6143.2002.20501.x","volume":"2","author":"CW Yang","year":"2002","unstructured":"Yang CW, Faulkner GR, Wahba IM, Christianson TA, Bagby GC, Jin DC, Abboud HE, Andoh TF, Bennett WM (2002) Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice. Am J Transplant 2(5):391\u2013399","journal-title":"Am J Transplant"},{"issue":"4","key":"5635_CR38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1172\/JCI1497","volume":"101","author":"J Megyesi","year":"1998","unstructured":"Megyesi J, Safirstein RL, Price PM (1998) Induction of p21WAF1\/CIP1\/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101(4):777\u2013782","journal-title":"J Clin Invest"},{"issue":"10","key":"5635_CR39","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/ptr.3207","volume":"24","author":"L Abenavoli","year":"2010","unstructured":"Abenavoli L, Capasso R, Milic N, Capasso F (2010) Milk thistle in liver diseases: past, present, future. Phytother Res 24(10):1423\u20131432","journal-title":"Phytother Res"},{"issue":"5","key":"5635_CR40","first-page":"306","volume":"43","author":"SK Das","year":"2006","unstructured":"Das SK, Vasudevan DM (2006) Protective effects of silymarin, a milk thistle (Silybium marianum) derivative on ethanol-induced oxidative stress in liver. Indian J Biochem Biophys 43(5):306\u2013311","journal-title":"Indian J Biochem Biophys"},{"issue":"1","key":"5635_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/antiox4010204","volume":"4","author":"PF Surai","year":"2015","unstructured":"Surai PF (2015) Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants (Basel) 4(1):204\u2013247","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"5635_CR42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3109\/0886022X.2010.486488","volume":"32","author":"G Vessal","year":"2010","unstructured":"Vessal G, Akmali M, Najafi P, Moein MR, Sagheb MM (2010) Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Ren Fail 32(6):733\u2013739","journal-title":"Ren Fail"},{"issue":"9","key":"5635_CR43","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","volume":"68","author":"S Elyasi","year":"2012","unstructured":"Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A (2012) Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol 68(9):1243\u20131255","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05635-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T13:00:02Z","timestamp":1723208402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05635-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5635"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05635-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"19 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethical committee of GC University, Lahore, Pakistan (Ref. No. GCU\/IIB\/233). Consent to participate is not applicable in this case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}